Vitiligo
📧 Sign up to get email alerts when something new happens for Vitiligo.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-21Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo. [Phase 2]
A Phase 2 trial evaluating VYN201 Gel in non-segmental vitiligo has been terminated; the sponsor Vyne Therapeutics Inc. reports the study st…
-
CLINICAL_TRIALS withdrawal · 2024-09-24Clinical Trial Update: Evaluating the Efficacy and Safety of Metformin in Vitiligo [Phase 2]
Phase 2 clinical trial evaluating metformin for vitiligo has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-03-10Clinical Trial Update: Comparative Study of Techniques in Melanocyte-Keratinocyte Transplantation for the Treatment of Vitiligo [Phase 2, Phase 3]
A Phase 2/3 comparative study of melanocyte-keratinocyte transplantation techniques for treating vitiligo was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-04-18Clinical Trial Update: Fractional Laser in Combination With UVB Therapy in Vitiligo Patients [NA]
The clinical trial evaluating fractional laser in combination with UVB therapy for vitiligo has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-03-16Clinical Trial Update: Efficacy and Safety of ACH24 in the Treatment of Vitiligo [Phase 3]
A Phase 3 clinical trial evaluating ACH24 for vitiligo has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2011-08-03Clinical Trial Update: Topical Bimatoprost Solution 0.03%in Stable Vitiligo [Phase 4]
Phase 4 trial of topical bimatoprost 0.03% for stable vitiligo has been withdrawn.